Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics)
Status:
COMPLETED
Trial end date:
2024-10-26
Target enrollment:
Participant gender:
Summary
This trial was divided into two parts. This is the scecond part. The second part is the pharmacodynamic equivalence study of patients, which is a single-dose, randomized, open, two-cycle, two-sequence crossover design, and plans to enroll 40 subjects.